Santhera Pharmaceuticals Holding AG

Swiss Stock Exchange:SANN.SW

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Switzerland

Market Cap

USD 239.69 M

Share Price

USD 18.63

Avg Daily Volume

29,393

Change (1 day)

0.29%

Change (1 year)

78.10%

Change (YTD)

21.90%

Santhera Pharmaceuticals Holding AG EBITDA Margin for the year ending December 31, 2024: -40.62%

Santhera Pharmaceuticals Holding AG EBITDA Margin is -40.62% for the year ending December 31, 2024, a -153.05% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Santhera Pharmaceuticals Holding AG EBITDA Margin for the year ending December 31, 2023 was 76.56%, a -112.23% change year over year.
Santhera Pharmaceuticals Holding AG EBITDA Margin for the year ending December 31, 2022 was -625.97%.
Santhera Pharmaceuticals Holding AG EBITDA Margin for the year ending December 31, 2020 was -356.00%, a 3,458.36% change year over year.